Use of primary radiotherapy for rectal cancer in the netherlands between 1997 and 2008: A population-based study

Clinical Oncology

Volumn 24, Issue 1, 2012, Pages

  Jobsen, J J ^a   Aarts, M J ^b   Siesling, S ^c,d   Klaase, J ^a   Louwman, W J ^b   Poortmans, P M P ^e   Lybeert, M L M ^f   Koning, C C E ^g   Struikmans, H ^h   Coebergh, J W W ^b,i  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c Integraal Kankercentrum Stedendriehoek Twente   (Netherlands)

^d UNIVERSITY OF TWENTE   (Netherlands)

^e Institute Verbeeten   (Netherlands)

^f CATHARINA HOSPITAL   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h MEDICAL CENTER HAAGLANDEN   (Netherlands)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Population based study; Radiotherapy; Rectal cancer; Referral; Utilisation rate

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION BASED CASE CONTROL STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM CANCER;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; RADIATION ONCOLOGY; RADIOTHERAPY; RECTAL NEOPLASMS;

EID: 84455199707     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.09.009     Document Type: Article

References (26)

1. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996, 3:423-430. Stockholm Colorectal Cancer Study Group.
2. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 1993, 80:1333-1336. Swedish Rectal Cancer Trial.
3. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
4. Oncoline 2010, Association of Comprehensive Cancer Centres, http://www.oncoline.nl/index.php?language=en.
5. Statistics Netherlands, 2010. http://www.statline.nl.
6. UICC International Union Against Cancer. TNM classification of malignant tumours 2009, Wiley-Liss, Geneva. L.H. Sobin, M.K. Gospodarowicz, C. Wittekind (Eds.).
7. Fritz A., Percy C., Jack A., et al. International classification of diseases for oncology 2000, World Health Organization, Geneva. 3rd ed.
8. Schouten L.J., Hoppener P., van den Brandt P.A., Knottnerus J.A., Jager J.J. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993, 22:369-376.
9. Marijnen C.A., Glimelius B. The role of radiotherapy in rectal cancer. Eur J Cancer 2002, 38:943-952.
10. Camma C., Giunta M., Fiorica F., Pagliaro L., Craxi A., Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. Jama 2000, 284:1008-1015.
11. Swedish Rectal Cancer Trial. N Engl J Med 1997, 336:980-987. Improved survival with preoperative radiotherapy in resectable rectal cancer.
12. Elferink M.A., van Steenbergen L.N., Krijnen P., et al. Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur JCancer 2010, 46:1421-1429.
13. Baxter N.N., Rothenberger D.A., Morris A.M., Bullard K.M. Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States. Dis Colon Rectum 2005, 48:9-15.
14. Delaney G., Barton M., Jacob S. Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence. Cancer 2004, 101:657-670.
15. Minsky B.D., Mies C., Rich T.A., Recht A. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys 1989, 17:311-318.
16. Valentini V., Aristei C., Glimelius B., et al. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009, 92:148-163.
17. Lidder P.G., Hosie K.B. Rectal cancer: the role of radiotherapy. Dig Surg 2005, 22:41-48. discussion 9.
18. Guillem J.G., Diaz-Gonzalez J.A., Minsky B.D., et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 2008, 26:368-373.
19. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291-1304.
20. Wong R.K., Berry S., Spithoff K., et al. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol) 2010, 22:265-271.
21. Colquhoun P., Wexner S.D., Cohen A. Adjuvant therapy is valuable in the treatment of rectal cancer despite total mesorectal excision. J Surg Oncol 2003, 83:133-139.
22. Vulto J.C., Louwman W.J., Poortmans P.M., Coebergh J.W. Hospital variation in referral for primary radiotherapy in South Netherlands, 1988-1999. Eur J Cancer 2005, 41:2722-2727.
23. Vulto A.J., Lemmens V.E., Louwman M.W., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer 2006, 106:2734-2742.
24. Shahir M.A., Lemmens V.E., van de Poll-Franse L.V., Voogd A.C., Martijn H., Janssen-Heijnen M.L. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 2006, 42:3015-3021.
25. Lemmens V.E., Janssen-Heijnen M.L., Verheij C.D., Houterman S., Repelaer van Driel O.J., Coebergh J.W. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005, 92:615-623.
26. Martijn H., Vulto J.C. Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer?. Eur J Cancer 2007, 43:2301-2306.